Clinical Trial

Clinical Trial of the Cryosa System for the Treatment of Obstructive Sleep Apnea

Study acronym: ARCTIC-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This is a prospective, multicenter, non-randomized single-arm safety and performance study to collect data to evaluate the safety of the Cryosa procedure to treat obstructive sleep apnea (OSA) in patients with moderate to severe OSA. The study will also evaluate the chronic performance of the Cryosa system and collect clinical measures for therapy effectiveness that will be used to demonstrate safety and effectiveness in the next clinical study.
Protocol Amendment History 5 changes
critical Enrollment closed, study ongoing 2026-08-12
notable Primary completion pushed: 2026-12-30 -> 2027-01-30 2026-08-12
minor Completion pushed: 2028-06-30 -> 2028-07-30 2026-08-12
notable Primary completion pushed: 2026-06-30 -> 2026-12-30 2026-05-01
minor Completion pushed: 2028-03-31 -> 2028-06-30 2026-05-01
Trial Details
NCT Number NCT06008626
Lead Sponsor Cryosa, Inc.
Conditions Obstructive Sleep Apnea of Adult
Enrollment 25 participants
Start Date 2023-09-12
Primary Completion 2027-01-30 (estimated)
Study Completion 2028-07-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-11